Evaluate the Safety and Efficacy of HG102 as Compared to Botox® in Subject With Moderate to Severe Glabellar Lines
NCT05801146
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
272
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Lines
Interventions
DRUG:
Botulinum Toxin Type A Injection [HG102]
DRUG:
Botulinum Toxin Type A Injection [Botox]
Sponsor
Hugel